Journal of Immunology Research

Autoantibodies in Systemic Autoimmune Disorders


Publishing date
09 May 2014
Status
Published
Submission deadline
13 Dec 2013

Lead Editor

1INOVA Diagnostics, San Diego, CA, USA

2Division of Rheumatology, Department of Internal Medicine, University of Texas, Medical Branch, Galveston ,TX, USA

3Department of Rheumatology, University of Milan, Milan, Italy

4Faculty of Medicine, University of Calgary, Calgary, AB, Canada


Autoantibodies in Systemic Autoimmune Disorders

Description

We invite authors to submit original research and review articles that seek to provide novel insights in the B-cell immune response of systemic autoimmune diseases. We are interested in articles that explore novel aspects of autoantibody detection as an aid in the diagnosis of systemic autoimmunity and also in in vivo aspects of autoantibodies. Potential topics include, but are not limited to:

  • Novel, cutting-edge technologies for the identification of autoantigens
  • Novel biomarkers in autoimmunity
  • Diagnostic, clinical, and prognostic significance of autoantibodies
  • Performance and analytical characteristics of novel immunoassays for autoantibody testing
  • Engineered designer autoantigens: peptides and recombinant antigens

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/jir/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/jir/asads/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 263091
  • - Editorial

Autoantibodies in Systemic Autoimmune Disorders

Michael Mahler | Silvia Pierangeli | ... | Marvin J. Fritzler
  • Special Issue
  • - Volume 2014
  • - Article ID 516593
  • - Research Article

Anti-hnRNP B1 (RA33) Autoantibodies Are Associated with the Clinical Phenotype in Russian Patients with Rheumatoid Arthritis and Systemic Sclerosis

Aleksey Maslyanskiy | Natalya Lazareva | ... | Dirk Roggenbuck
  • Special Issue
  • - Volume 2014
  • - Article ID 315179
  • - Review Article

Current Concepts and Future Directions for the Assessment of Autoantibodies to Cellular Antigens Referred to as Anti-Nuclear Antibodies

Michael Mahler | Pier-Luigi Meroni | ... | Marvin J. Fritzler
  • Special Issue
  • - Volume 2014
  • - Article ID 809389
  • - Research Article

Chinese SLE Treatment and Research Group Registry: III. Association of Autoantibodies with Clinical Manifestations in Chinese Patients with Systemic Lupus Erythematosus

Jing Li | Xiaomei Leng | ... | Xiaofeng Zeng
  • Special Issue
  • - Volume 2014
  • - Article ID 672126
  • - Research Article

Antilymphocyte Antibodies in Systemic Lupus Erythematosus: Association with Disease Activity and Lymphopenia

Chun Li | Rong Mu | ... | Zhan-guo Li
  • Special Issue
  • - Volume 2014
  • - Article ID 536050
  • - Research Article

Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis

Laura Gonzalez-Lopez | Alberto Daniel Rocha-Muñoz | ... | Jorge Ivan Gamez-Nava
  • Special Issue
  • - Volume 2014
  • - Article ID 320674
  • - Review Article

Acquired Hemophilia A: A Frequently Overlooked Autoimmune Hemorrhagic Disorder

Yoshihiko Sakurai | Tomohiro Takeda
  • Special Issue
  • - Volume 2014
  • - Article ID 704395
  • - Research Article

Isolated IgA Anti-β2 Glycoprotein I Antibodies in Patients with Clinical Criteria for Antiphospholipid Syndrome

Raquel Ruiz-García | Manuel Serrano | ... | Antonio Serrano
  • Special Issue
  • - Volume 2014
  • - Article ID 389601
  • - Research Article

The Mosaic of “Seronegative” Antiphospholipid Syndrome

Fabrizio Conti | Antonella Capozzi | ... | Maurizio Sorice
  • Special Issue
  • - Volume 2014
  • - Article ID 401739
  • - Research Article

Anti-Nuclear Antibodies in Daily Clinical Practice: Prevalence in Primary, Secondary, and Tertiary Care

Thomas Y. Avery | Mart van de Cruys | ... | Jan G. M. C. Damoiseaux
Journal of Immunology Research
 Journal metrics
Acceptance rate40%
Submission to final decision64 days
Acceptance to publication30 days
CiteScore3.330
Impact Factor3.404
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.